FOXM1: A small fox that makes more tracks for cancer progression and metastasis

Md Arafat Khan, Parvez Khan, Aatiya Ahmad, Mahek Fatima, Mohd Wasim Nasser

Research output: Contribution to journalReview articlepeer-review

17 Scopus citations

Abstract

Transcription factors (TFs) are indispensable for the modulation of various signaling pathways associated with normal cell homeostasis and disease conditions. Among cancer-related TFs, FOXM1 is a critical molecule that regulates multiple aspects of cancer cells, including growth, metastasis, recurrence, and stem cell features. FOXM1 also impact the outcomes of targeted therapies, chemotherapies, and immune checkpoint inhibitors (ICIs) in various cancer types. Recent advances in cancer research strengthen the cancer-specific role of FOXM1, providing a rationale to target FOXM1 for developing targeted therapies. This review compiles the recent studies describing the pivotal role of FOXM1 in promoting metastasis of various cancer types. It also implicates the contribution of FOXM1 in the modulation of chemotherapeutic resistance, antitumor immune response/immunotherapies, and the potential of small molecule inhibitors of FOXM1.

Original languageEnglish (US)
Pages (from-to)1-15
Number of pages15
JournalSeminars in Cancer Biology
Volume92
DOIs
StatePublished - Jul 2023

Keywords

  • Chemoresistance
  • Metastasis
  • Recurrence
  • Subtype switching
  • Transcription factors

ASJC Scopus subject areas

  • Cancer Research

Fingerprint

Dive into the research topics of 'FOXM1: A small fox that makes more tracks for cancer progression and metastasis'. Together they form a unique fingerprint.

Cite this